Feb 22, 2012

FDA advisers back experimental obesity pill

An experimental obesity drug from Vivus Inc won the backing of a U.S. advisory panel on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years.

US FDA panel gives nod to Vivus obesity drug | Reuters
WASHINGTON, Feb 22 (Reuters) - An experimental obesitydrug from Vivus Inc won a U.S. panel's support onWednesday, raising hopes regulators would approve a weight-losspill for the first time in 13 years.A